Results 61 to 70 of about 256,366 (275)

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

open access: yesMolecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu   +10 more
wiley   +1 more source

JNDS, Volume 22, Number 3

open access: yes, 2004
Review of the book "Religion, Spirituality and the Near-Death Experience" written by British scholar Mark ...
Gunn, Susan C.
core   +2 more sources

Recalled Experience of Death: transcending the cerebrocentric model of consciousness [PDF]

open access: yesInterface: Comunicação, Saúde, Educação
To explore the scientific approach to Recalled Experience of Death (RED) and correlate it with the philosophical foundations of Family and Community Medicine to expand the understanding of the human consciousness. Non-systematic review on PubMed database
Armando Henrique Norman   +1 more
doaj   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

open access: yesMolecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena   +15 more
wiley   +1 more source

Western Scientific Approaches to Near-Death Experiences

open access: yesHumanities, 2015
Near-death experiences (NDEs) are vivid experiences that often occur in life-threatening conditions, usually characterized by a transcendent tone and clear perceptions of leaving the body and being in a different spatiotemporal dimension.
Bruce Greyson
doaj   +1 more source

ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma‐cfDNA of advanced breast cancer patients: A feasibility proof‐of‐concept study

open access: yesMolecular Oncology, EarlyView.
Circulating tumor cells (CTCs) and plasma cell‐free DNA (cfDNA) were analyzed to detect ESR1 mutations and methylation in patients with advanced breast cancer. CTC‐derived DNA showed higher sensitivity for mutation detection and revealed complementary genetic and epigenetic alterations, highlighting the added value of CTC analysis for understanding ...
Dimitra Stergiopoulou   +12 more
wiley   +1 more source

JNDS, Volume 25, Number 1

open access: yes, 2006
Article discussing the near-death experience (NDE) of George de Benneville during the 18th century, regarding his autobiographical account of the religious vision he had during his experience.
Morgan, John C., Vincent, Ken R.
core   +2 more sources

The intertwining of death and life: a hermeneutic phenomenological investigation of near-death experiences among coma survivors

open access: yesBMC Psychology
Background Death is an experience that every human being faces. As such, the near-death experience (NDE) has been a topic of interest to humanity for millennia.
Hajar Behzadi   +4 more
doaj   +1 more source

EEG signature of near-death-like experiences during syncope-induced periods of unresponsiveness

open access: yesNeuroImage
During fainting, disconnected consciousness may emerge in the form of dream-like experiences. Characterized by extra-ordinary and mystical features, these subjective experiences have been associated to near-death-like experiences (NDEs-like). We here aim
Charlotte Martial   +6 more
doaj   +1 more source

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

open access: yesMolecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy